Reaction
Acquired Immunodeficiency Syndrome reporting signals
As of the last recalculation, Acquired Immunodeficiency Syndrome appears in 508 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is LOPINAVIR AND RITONAVIR (PRR 127.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lopinavir And Ritonavir | 39 | 127.6 | 128.0 |
| Abacavir Sulfate | 21 | 92.1 | 92.3 |
| Zidovudine | 26 | 83.9 | 84.1 |
| Nevirapine | 17 | 79.8 | 80.0 |
| Ritonavir | 45 | 69.1 | 69.2 |
| Lamivudine | 47 | 68.6 | 68.7 |
| Efavirenz | 18 | 68.5 | 68.7 |
| Tenofovir Disoproxil Fumarate Tablets | 13 | 63.3 | 63.4 |
| Lamivudine Oral | 36 | 62.7 | 62.8 |
| Ritonavir 100 Mg | 20 | 57.1 | 57.1 |
| Dolutegravir Sodium | 12 | 55.8 | 55.9 |
| Atazanavir | 18 | 53.2 | 53.2 |
| Tenofovir Disoproxil Fumarate | 38 | 50.8 | 50.9 |
| Darunavir | 17 | 47.6 | 47.7 |
| Raltegravir | 16 | 41.0 | 41.0 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 35 | 33.7 | 33.7 |
| Atovaquone | 6 | 30.9 | 30.9 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 10 | 23.0 | 23.1 |
| Emtricitabine And Tenofovir Alafenamide | 5 | 18.2 | 18.2 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 4 | 16.4 | 16.4 |